Binyu Zhu
No. 800 Dongchuan Road
Shanghai, 200240, China
Shanghai, 200240, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A NIR-IIb-excited capsule endoscope enabling high-contrast fluorescence imaging via spectrally-isolated detection for early-stage gastrointestinal cancer.
Journal: Journal of nanobiotechnology
Published: November 16, 2025
Cartilage targeting hydrogel nanoplatform degrades BRD4 to alleviate osteoarthritis via Nav1.7 axis.
Cartilage targeting hydrogel nanoplatform degrades BRD4 to alleviate osteoarthritis via Nav1.7 axis.
Journal: Nature communications
Published: August 22, 2025
AMFR-mediated ER-phagy regulation and therapeutic targeting in osteosarcoma: a multifunctional nanoplatform strategy.
Journal: Journal of nanobiotechnology
Published: June 12, 2025
Computer-Aided Design of Self-Assembled Nanoparticles to Enhance Cancer Chemoimmunotherapy via Dual-Modulation Strategy.
Journal: Advanced healthcare materials
Published: October 31, 2024
5-Fluorouracil Loaded Prebiotic-Probiotic Liposomes Modulating Gut Microbiota for Improving Colorectal Cancer Chemotherapy.
Journal: Advanced healthcare materials
Published: September 19, 2024
Conformation Influences Biological Fates of Peptide-Based Nanofilaments by Modulating Protein Adsorption and Interfilament Entanglement.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: June 26, 2024
Rational strategies for improving the efficiency of design and discovery of nanomedicines.
Journal: Nature communications
Published: June 16, 2024
Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles.
Journal: Acta pharmaceutica Sinica. B
Published: December 04, 2023
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer.
Journal: Nature communications
Published: November 15, 2023
Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 19, 2023
Inhibiting Endothelial Cell-Mediated T Lymphocyte Apoptosis with Integrin-Targeting Peptide-Drug Conjugate Filaments for Chemoimmunotherapy of Triple-Negative Breast Cancer.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: July 08, 2023
Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer.
Journal: Acta pharmaceutica Sinica. B
Published: November 30, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026